The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo

被引：42
|
作者：
Keren, Aviad [1 ]
Shemer, Avner [1 ]
Ullmann, Yehuda [1 ]
Paus, Ralf [2 ,3 ]
Gilhar, Amos [1 ]
机构：
[1] Technion Israel Inst Technol, Fac Med, Flieman Med Ctr, Skin Res Lab, IL-31096 Haifa, Israel
[2] Univ Manchester, Ctr Dermatol Res, Inst Inflammat & Repair, Manchester, Lancs, England
[3] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
来源：
JOURNAL OF DERMATOLOGICAL SCIENCE | 2015年 / 77卷 / 01期
关键词：
MODEL;
D O I：
10.1016/j.jdermsci.2014.11.009
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：74 / 76
页数：3
相关论文
共 50 条
  • [21] Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease
    Young, Melodie
    Roebuck, Heather L.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2016, 28 (12) : 683 - 695
  • [22] Secretagogue effect of PDE4 inhibitor apremilast on human salivary gland organoids obtained from primary Sjögren's syndrome patients
    Manfre, V.
    Parisi, S.
    Caligiuri, I.
    Repetto, O.
    Zabotti, A.
    Pegolo, E.
    Fabro, C.
    De Vita, S.
    Canzonieri, V.
    Di Loreto, C.
    Rizzolio, F.
    Quartuccio, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (12) : 2493 - 2501
  • [23] Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice
    Boyd, Abigail
    Aragon, Ileana V.
    Rich, Justin
    McDonough, Will
    Oditt, Marianna
    Irelan, Daniel
    Fiedler, Edward
    Abou Saleh, Lina
    Richter, Wito
    BIOLOGY-BASEL, 2021, 10 (12):
  • [24] Ariflo, an inhibitor of PDE4 phosphodiesterase, suppresses the growth of human acute lymphoblastic leukemia cells and augments glucocorticoid sensitivity.
    Kato, GJ
    Bugayenko, A
    BLOOD, 2001, 98 (11) : 304A - 304A
  • [25] Cilomilast, an inhibitor of PDE4 phosphodiesterase, suppresses the growth of human acute lymphoblastic leukemia cells and augments glucocorticoid sensitivity.
    Kato, GJ
    Bugayenko, A
    PEDIATRIC RESEARCH, 2002, 51 (04) : 234A - 234A
  • [26] In vivo efficacy of CHF6001, an inhaled PDE4 inhibitor with a wide therapeutic window
    Villetti, Gino
    Bolzoni, Pier Tonino
    Bassani, Franco
    Bergamaschi, Marco
    Caruso, Paola Lorenza
    Battipaglia, Loredana
    Sala, Angelo
    Facchinetti, Fabrizio
    Carnini, Chiara
    Civelli, Maurizio
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [27] In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor
    Bundschuh, DS
    Eltze, M
    Barsig, J
    Wollin, L
    Hatzelmann, A
    Beume, R
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (01): : 280 - 290
  • [28] The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils
    Schioppa, Tiziana
    Nguyen, Hoang Oanh
    Salvi, Valentina
    Maugeri, Norma
    Facchinetti, Fabrizio
    Villetti, Gino
    Civelli, Maurizio
    Gaudenzi, Carolina
    Passari, Mauro
    Sozio, Francesca
    Barbazza, Ilaria
    Tamassia, Nicola
    Cassatella, Marco A.
    Del Prete, Annalisa
    Bosisio, Daniela
    Tiberio, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [29] Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice
    Nazir, Samra
    Anwar, Fareeha
    Saleem, Uzma
    Ahmad, Bashir
    Raza, Zohaib
    Sanawar, Maham
    Rehman, Artta Ur
    Ismail, Tariq
    NEUROCHEMICAL RESEARCH, 2021, 46 (07) : 1814 - 1829
  • [30] Inhibition of PDE4 by apremilast attenuates skin fibrosis through directly suppressing activation of M1 and T cells
    Lu, Qiu-kai
    Fan, Chen
    Xiang, Cai-gui
    Wu, Bing
    Lu, Hui-min
    Feng, Chun-lan
    Yang, Xiao-qian
    Li, Heng
    Tang, Wei
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (02) : 376 - 386
12345